ID   ACADS_HUMAN             Reviewed;         412 AA.
AC   P16219; P78331;
DT   01-APR-1990, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1990, sequence version 1.
DT   15-MAR-2017, entry version 190.
DE   RecName: Full=Short-chain specific acyl-CoA dehydrogenase, mitochondrial;
DE            Short=SCAD;
DE            EC=1.3.8.1;
DE   AltName: Full=Butyryl-CoA dehydrogenase;
DE   Flags: Precursor;
GN   Name=ACADS;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2565344; DOI=10.1172/JCI114058;
RA   Naito E., Ozasa H., Ikeda Y., Tanaka K.;
RT   "Molecular cloning and nucleotide sequence of complementary DNAs
RT   encoding human short chain acyl-coenzyme A dehydrogenase and the study
RT   of the molecular basis of human short chain acyl-coenzyme A
RT   dehydrogenase deficiency.";
RL   J. Clin. Invest. 83:1605-1613(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=9383286; DOI=10.1007/s003359900612;
RA   Corydon M.J., Andresen B.S., Bross P., Kjeldsen M., Andreasen P.H.,
RA   Eiberg H., Koelvraa S., Gregersen N.;
RT   "Structural organization of the human short-chain acyl-CoA
RT   dehydrogenase gene.";
RL   Mamm. Genome 8:922-926(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Yamagata K., Oda N., Furuta H., Vaxillaire M., Southam L., Boriraj V.,
RA   Chen X., Oda Y., Takeda J., Yamada S., Nishigori H., Lebeau M.M.,
RA   Lathrop M., Cox R.D., Bell G.I.;
RT   "Transcription map of the 5cM region surrounding the hepatocyte
RT   nuclear factor-1a/MODY3 gene on chromosome 12.";
RL   Submitted (JAN-1997) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Retinal pigment epithelium;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   PROTEIN SEQUENCE OF 25-34.
RC   TISSUE=Liver;
RX   PubMed=1286669; DOI=10.1002/elps.11501301201;
RA   Hochstrasser D.F., Frutiger S., Paquet N., Bairoch A., Ravier F.,
RA   Pasquali C., Sanchez J.-C., Tissot J.-D., Bjellqvist B., Vargas R.,
RA   Appel R.D., Hughes G.J.;
RT   "Human liver protein map: a reference database established by
RT   microsequencing and gel comparison.";
RL   Electrophoresis 13:992-1001(1992).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 30-412 IN COMPLEX WITH FAD
RP   AND SUBSTRATE ANALOG, AND COFACTOR.
RG   Structural genomics consortium (SGC);
RT   "Crystal structure of human RAB14.";
RL   Submitted (FEB-2009) to the PDB data bank.
RN   [10]
RP   VARIANTS ACADSD.
RX   PubMed=1692038; DOI=10.1172/JCI114607;
RA   Naito E., Indo Y., Tanaka K.;
RT   "Identification of two variant short chain acyl-coenzyme A
RT   dehydrogenase alleles, each containing a different point mutation in a
RT   patient with short chain acyl-coenzyme A dehydrogenase deficiency.";
RL   J. Clin. Invest. 85:1575-1582(1990).
RN   [11]
RP   VARIANTS ACADSD CYS-92; ARG-177 AND CYS-383, AND VARIANTS TRP-171 AND
RP   SER-209.
RX   PubMed=9499414; DOI=10.1093/hmg/7.4.619;
RA   Gregersen N., Winter V.S., Corydon M.J., Corydon T.J., Rinaldo P.,
RA   Ribes A., Martinez G., Bennett M.J., Vianey-Saban C., Bhala A.,
RA   Hale D.E., Lehnert W., Kmoch S., Roig M., Riudor E., Eiberg H.,
RA   Andresen B.S., Bross P., Bolund L.A., Koelvraa S.;
RT   "Identification of four new mutations in the short-chain acyl-CoA
RT   dehydrogenase (SCAD) gene in two patients: one of the variant alleles,
RT   511C-->T, is present at an unexpectedly high frequency in the general
RT   population, as was the case for 625G-->A, together conferring
RT   susceptibility to ethylmalonic aciduria.";
RL   Hum. Mol. Genet. 7:619-627(1998).
RN   [12]
RP   VARIANTS ACADSD SER-90; GLU-104 DEL; VAL-192; TRP-325; LEU-353 AND
RP   TRP-380, AND VARIANTS TRP-171 AND SER-209.
RX   PubMed=11134486; DOI=10.1203/00006450-200101000-00008;
RA   Corydon M.J., Vockley J., Rinaldo P., Rhead W.J., Kjeldsen M.,
RA   Winter V.S., Riggs C., Babovic-Vuksanovic D., Smeitink J., De Jong J.,
RA   Levy H., Sewell A.C., Roe C., Matern D., Dasouki M., Gregersen N.;
RT   "Role of common gene variations in the molecular pathogenesis of
RT   short-chain acyl-CoA dehydrogenase deficiency.";
RL   Pediatr. Res. 49:18-23(2001).
CC   -!- FUNCTION: Introduces a double bond at position 2 in saturated
CC       acyl-CoA's of short chain length, i.e. less than 6 carbon atoms.
CC       {ECO:0000250|UniProtKB:P15651}.
CC   -!- CATALYTIC ACTIVITY: A short-chain acyl-CoA + electron-transfer
CC       flavoprotein = a short-chain trans-2,3-dehydroacyl-CoA + reduced
CC       electron-transfer flavoprotein. {ECO:0000250|UniProtKB:P15651}.
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692; Evidence={ECO:0000269|Ref.9};
CC       Note=Binds 1 FAD per subunit. {ECO:0000269|Ref.9};
CC   -!- PATHWAY: Lipid metabolism; mitochondrial fatty acid beta-
CC       oxidation.
CC   -!- SUBUNIT: Homotetramer. {ECO:0000269|Ref.9}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion matrix.
CC   -!- DISEASE: Acyl-CoA dehydrogenase short-chain deficiency (ACADSD)
CC       [MIM:201470]: An inborn error of mitochondrial fatty acid beta-
CC       oxidation resulting in acute acidosis and muscle weakness in
CC       infants, and a form of lipid-storage myopathy in adults.
CC       {ECO:0000269|PubMed:11134486, ECO:0000269|PubMed:1692038,
CC       ECO:0000269|PubMed:9499414}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- MISCELLANEOUS: A number of straight-chain acyl-CoA dehydrogenases
CC       of different substrate specificities are present in mammalian
CC       tissues.
CC   -!- SIMILARITY: Belongs to the acyl-CoA dehydrogenase family.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Butyryl-CoA dehydrogenase
CC       entry;
CC       URL="https://en.wikipedia.org/wiki/Butyryl_CoA_dehydrogenase";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M26393; AAA60307.1; -; mRNA.
DR   EMBL; Z80345; CAB02492.1; -; Genomic_DNA.
DR   EMBL; Z80347; CAB02492.1; JOINED; Genomic_DNA.
DR   EMBL; U83992; AAD00552.1; -; Genomic_DNA.
DR   EMBL; U83991; AAD00552.1; JOINED; Genomic_DNA.
DR   EMBL; BC025963; AAH25963.1; -; mRNA.
DR   CCDS; CCDS9207.1; -.
DR   PIR; A30605; A30605.
DR   RefSeq; NP_000008.1; NM_000017.3.
DR   RefSeq; NP_001289483.1; NM_001302554.1.
DR   UniGene; Hs.507076; -.
DR   PDB; 2VIG; X-ray; 1.90 A; A/B/C/D/E/F/G/H=30-412.
DR   PDBsum; 2VIG; -.
DR   ProteinModelPortal; P16219; -.
DR   SMR; P16219; -.
DR   BioGrid; 106553; 12.
DR   IntAct; P16219; 2.
DR   STRING; 9606.ENSP00000242592; -.
DR   DrugBank; DB03059; Acetoacetyl-Coenzyme A.
DR   DrugBank; DB03147; Flavin adenine dinucleotide.
DR   DrugBank; DB00157; NADH.
DR   SwissLipids; SLP:000001403; -.
DR   iPTMnet; P16219; -.
DR   PhosphoSitePlus; P16219; -.
DR   BioMuta; ACADS; -.
DR   DMDM; 113019; -.
DR   DOSAC-COBS-2DPAGE; P16219; -.
DR   SWISS-2DPAGE; P16219; -.
DR   UCD-2DPAGE; P16219; -.
DR   EPD; P16219; -.
DR   MaxQB; P16219; -.
DR   PaxDb; P16219; -.
DR   PeptideAtlas; P16219; -.
DR   PRIDE; P16219; -.
DR   DNASU; 35; -.
DR   Ensembl; ENST00000242592; ENSP00000242592; ENSG00000122971.
DR   GeneID; 35; -.
DR   KEGG; hsa:35; -.
DR   UCSC; uc001tza.5; human.
DR   CTD; 35; -.
DR   DisGeNET; 35; -.
DR   GeneCards; ACADS; -.
DR   GeneReviews; ACADS; -.
DR   HGNC; HGNC:90; ACADS.
DR   HPA; CAB019284; -.
DR   HPA; HPA004799; -.
DR   HPA; HPA022271; -.
DR   MalaCards; ACADS; -.
DR   MIM; 201470; phenotype.
DR   MIM; 606885; gene.
DR   neXtProt; NX_P16219; -.
DR   OpenTargets; ENSG00000122971; -.
DR   Orphanet; 26792; Short chain acyl-CoA dehydrogenase deficiency.
DR   PharmGKB; PA24426; -.
DR   eggNOG; KOG0139; Eukaryota.
DR   eggNOG; COG1960; LUCA.
DR   GeneTree; ENSGT00760000119007; -.
DR   HOGENOM; HOG000131659; -.
DR   HOVERGEN; HBG000224; -.
DR   InParanoid; P16219; -.
DR   KO; K00248; -.
DR   OMA; VYVIFAM; -.
DR   OrthoDB; EOG091G04BS; -.
DR   PhylomeDB; P16219; -.
DR   TreeFam; TF105019; -.
DR   BioCyc; MetaCyc:HS04619-MONOMER; -.
DR   Reactome; R-HSA-77350; Beta oxidation of hexanoyl-CoA to butanoyl-CoA.
DR   Reactome; R-HSA-77352; Beta oxidation of butanoyl-CoA to acetyl-CoA.
DR   SABIO-RK; P16219; -.
DR   UniPathway; UPA00660; -.
DR   EvolutionaryTrace; P16219; -.
DR   GenomeRNAi; 35; -.
DR   PRO; PR:P16219; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000122971; -.
DR   CleanEx; HS_ACADS; -.
DR   ExpressionAtlas; P16219; baseline and differential.
DR   Genevisible; P16219; HS.
DR   GO; GO:0005759; C:mitochondrial matrix; TAS:Reactome.
DR   GO; GO:0005739; C:mitochondrion; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0003995; F:acyl-CoA dehydrogenase activity; TAS:Reactome.
DR   GO; GO:0004085; F:butyryl-CoA dehydrogenase activity; IEA:UniProtKB-EC.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; IEA:InterPro.
DR   GO; GO:0006635; P:fatty acid beta-oxidation; TAS:Reactome.
DR   Gene3D; 1.10.540.10; -; 1.
DR   InterPro; IPR006089; Acyl-CoA_DH_CS.
DR   InterPro; IPR006091; Acyl-CoA_Oxase/DH_cen-dom.
DR   InterPro; IPR009075; AcylCo_DH/oxidase_C.
DR   InterPro; IPR013786; AcylCoA_DH/ox_N.
DR   InterPro; IPR009100; AcylCoA_DH/oxidase_NM_dom.
DR   Pfam; PF00441; Acyl-CoA_dh_1; 1.
DR   Pfam; PF02770; Acyl-CoA_dh_M; 1.
DR   Pfam; PF02771; Acyl-CoA_dh_N; 1.
DR   SUPFAM; SSF47203; SSF47203; 1.
DR   SUPFAM; SSF56645; SSF56645; 1.
DR   PROSITE; PS00072; ACYL_COA_DH_1; 1.
DR   PROSITE; PS00073; ACYL_COA_DH_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Complete proteome;
KW   Direct protein sequencing; Disease mutation; FAD;
KW   Fatty acid metabolism; Flavoprotein; Lipid metabolism; Mitochondrion;
KW   Oxidoreductase; Phosphoprotein; Polymorphism; Reference proteome;
KW   Transit peptide.
FT   TRANSIT       1     24       Mitochondrion.
FT                                {ECO:0000269|PubMed:1286669}.
FT   CHAIN        25    412       Short-chain specific acyl-CoA
FT                                dehydrogenase, mitochondrial.
FT                                /FTId=PRO_0000000498.
FT   NP_BIND     152    161       FAD. {ECO:0000269|Ref.9}.
FT   NP_BIND     185    187       FAD. {ECO:0000269|Ref.9}.
FT   NP_BIND     365    369       FAD; shared with dimeric partner.
FT                                {ECO:0000269|Ref.9}.
FT   NP_BIND     394    396       FAD. {ECO:0000269|Ref.9}.
FT   REGION      269    272       Substrate binding.
FT   ACT_SITE    392    392       Proton acceptor.
FT                                {ECO:0000250|UniProtKB:P15651}.
FT   BINDING     161    161       Substrate; via carbonyl oxygen.
FT   BINDING     297    297       FAD; shared with dimeric partner.
FT                                {ECO:0000269|Ref.9}.
FT   BINDING     308    308       FAD. {ECO:0000269|Ref.9}.
FT   BINDING     393    393       Substrate; via amide nitrogen.
FT   MOD_RES      27     27       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q07417}.
FT   MOD_RES      51     51       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q07417}.
FT   MOD_RES      51     51       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q07417}.
FT   MOD_RES      72     72       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q07417}.
FT   MOD_RES     129    129       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q07417}.
FT   MOD_RES     129    129       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q07417}.
FT   MOD_RES     208    208       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q07417}.
FT   MOD_RES     262    262       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q07417}.
FT   MOD_RES     262    262       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q07417}.
FT   MOD_RES     306    306       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q07417}.
FT   MOD_RES     306    306       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q07417}.
FT   VARIANT      46     46       R -> W (in ACADSD; dbSNP:rs121908003).
FT                                /FTId=VAR_000310.
FT   VARIANT      90     90       G -> S (in ACADSD; no detectable
FT                                activity; dbSNP:rs121908005).
FT                                {ECO:0000269|PubMed:11134486}.
FT                                /FTId=VAR_013565.
FT   VARIANT      92     92       G -> C (in ACADSD; dbSNP:rs121908004).
FT                                {ECO:0000269|PubMed:9499414}.
FT                                /FTId=VAR_000311.
FT   VARIANT     104    104       Missing (in ACADSD; no detectable
FT                                activity). {ECO:0000269|PubMed:11134486}.
FT                                /FTId=VAR_013566.
FT   VARIANT     107    107       R -> C (in ACADSD; dbSNP:rs61732144).
FT                                /FTId=VAR_000312.
FT   VARIANT     171    171       R -> W (69% of wild-type activity;
FT                                confers susceptibility to
FT                                ethylmalonicaciduria; dbSNP:rs1800556).
FT                                {ECO:0000269|PubMed:11134486,
FT                                ECO:0000269|PubMed:9499414}.
FT                                /FTId=VAR_013567.
FT   VARIANT     177    177       W -> R (in ACADSD; dbSNP:rs57443665).
FT                                {ECO:0000269|PubMed:9499414}.
FT                                /FTId=VAR_000314.
FT   VARIANT     192    192       A -> V (in ACADSD; no detectable
FT                                activity; dbSNP:rs28940874).
FT                                {ECO:0000269|PubMed:11134486}.
FT                                /FTId=VAR_013568.
FT   VARIANT     209    209       G -> S (86% of wild-type activity;
FT                                confers susceptibility to
FT                                ethylmalonicaciduria; dbSNP:rs1799958).
FT                                {ECO:0000269|PubMed:11134486,
FT                                ECO:0000269|PubMed:9499414}.
FT                                /FTId=VAR_000315.
FT   VARIANT     325    325       R -> W (in ACADSD; no detectable
FT                                activity; dbSNP:rs121908006).
FT                                {ECO:0000269|PubMed:11134486}.
FT                                /FTId=VAR_013569.
FT   VARIANT     353    353       S -> L (in ACADSD; no detectable
FT                                activity; dbSNP:rs28941773).
FT                                {ECO:0000269|PubMed:11134486}.
FT                                /FTId=VAR_013570.
FT   VARIANT     380    380       R -> W (in ACADSD; no detectable
FT                                activity; dbSNP:rs28940875).
FT                                {ECO:0000269|PubMed:11134486}.
FT                                /FTId=VAR_013571.
FT   VARIANT     383    383       R -> C (in ACADSD; dbSNP:rs28940872).
FT                                {ECO:0000269|PubMed:9499414}.
FT                                /FTId=VAR_000316.
FT   VARIANT     383    383       R -> H (in dbSNP:rs35233375).
FT                                /FTId=VAR_033458.
FT   HELIX        36     52       {ECO:0000244|PDB:2VIG}.
FT   TURN         53     56       {ECO:0000244|PDB:2VIG}.
FT   HELIX        57     63       {ECO:0000244|PDB:2VIG}.
FT   HELIX        68     77       {ECO:0000244|PDB:2VIG}.
FT   TURN         78     80       {ECO:0000244|PDB:2VIG}.
FT   HELIX        86     88       {ECO:0000244|PDB:2VIG}.
FT   HELIX        95    108       {ECO:0000244|PDB:2VIG}.
FT   HELIX       110    121       {ECO:0000244|PDB:2VIG}.
FT   HELIX       124    130       {ECO:0000244|PDB:2VIG}.
FT   HELIX       133    139       {ECO:0000244|PDB:2VIG}.
FT   HELIX       141    143       {ECO:0000244|PDB:2VIG}.
FT   STRAND      144    147       {ECO:0000244|PDB:2VIG}.
FT   STRAND      150    153       {ECO:0000244|PDB:2VIG}.
FT   STRAND      159    162       {ECO:0000244|PDB:2VIG}.
FT   HELIX       163    165       {ECO:0000244|PDB:2VIG}.
FT   STRAND      169    173       {ECO:0000244|PDB:2VIG}.
FT   STRAND      176    187       {ECO:0000244|PDB:2VIG}.
FT   TURN        188    191       {ECO:0000244|PDB:2VIG}.
FT   STRAND      193    200       {ECO:0000244|PDB:2VIG}.
FT   STRAND      203    205       {ECO:0000244|PDB:2VIG}.
FT   STRAND      210    218       {ECO:0000244|PDB:2VIG}.
FT   STRAND      222    224       {ECO:0000244|PDB:2VIG}.
FT   STRAND      230    232       {ECO:0000244|PDB:2VIG}.
FT   STRAND      238    249       {ECO:0000244|PDB:2VIG}.
FT   HELIX       250    252       {ECO:0000244|PDB:2VIG}.
FT   STRAND      253    256       {ECO:0000244|PDB:2VIG}.
FT   HELIX       260    296       {ECO:0000244|PDB:2VIG}.
FT   HELIX       304    306       {ECO:0000244|PDB:2VIG}.
FT   HELIX       308    336       {ECO:0000244|PDB:2VIG}.
FT   HELIX       342    367       {ECO:0000244|PDB:2VIG}.
FT   HELIX       368    372       {ECO:0000244|PDB:2VIG}.
FT   HELIX       378    388       {ECO:0000244|PDB:2VIG}.
FT   TURN        389    392       {ECO:0000244|PDB:2VIG}.
FT   HELIX       395    411       {ECO:0000244|PDB:2VIG}.
SQ   SEQUENCE   412 AA;  44297 MW;  3E946ADFC3DA3C0E CRC64;
     MAAALLARAS GPARRALCPR AWRQLHTIYQ SVELPETHQM LLQTCRDFAE KELFPIAAQV
     DKEHLFPAAQ VKKMGGLGLL AMDVPEELGG AGLDYLAYAI AMEEISRGCA STGVIMSVNN
     SLYLGPILKF GSKEQKQAWV TPFTSGDKIG CFALSEPGNG SDAGAASTTA RAEGDSWVLN
     GTKAWITNAW EASAAVVFAS TDRALQNKGI SAFLVPMPTP GLTLGKKEDK LGIRGSSTAN
     LIFEDCRIPK DSILGEPGMG FKIAMQTLDM GRIGIASQAL GIAQTALDCA VNYAENRMAF
     GAPLTKLQVI QFKLADMALA LESARLLTWR AAMLKDNKKP FIKEAAMAKL AASEAATAIS
     HQAIQILGGM GYVTEMPAER HYRDARITEI YEGTSEIQRL VIAGHLLRSY RS
//
